How many clinical trials are studying NBI-1117568?

5 recruiting trials in our tracked data involve NBI-1117568.

What conditions is NBI-1117568 being studied for?

In our tracked recruiting trials, NBI-1117568 is being studied in trials for Schizophrenia, Bipolar I Disorder, Bipolar disorder.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 1 Phase 3 4

Condition	Trials
Schizophrenia · NBI-1117568 for Schizophrenia	4
Bipolar I Disorder	1
Bipolar disorder	1
Mania	1

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
NCT07288320 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 9 locations
Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
NCT07227818 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 20 locations
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
NCT06963034 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 21 locations
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
NCT07105098 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 15 locations
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
NCT07114874 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 57 locations